DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: OCREVUS (ocrelizumab)
       *****************************************************
       #Post#: 4464--------------------------------------------------
       Subcutaneous Ocrevus gets EU approval
       By: agate Date: June 26, 2024, 12:57 am
       ---------------------------------------------------------
       From Morningstar (June 24, 2024)--"Roche's Multiple Sclerosis
       Injection Gets EU Approval":
  HTML https://www.morningstar.com/news/dow-jones/20240625262/roches-multiple-sclerosis-injection-gets-eu-approval
       And from European Pharmaceutical Review (June 25)--New multiple
       sclerosis treatment option granted in EU":
  HTML https://www.europeanpharmaceuticalreview.com/news/230766/new-multiple-sclerosis-treatment-option-granted-in-eu/
       #Post#: 4483--------------------------------------------------
       (The Guardian) MS patients in England offered 10-minute jab in p
       lace of infusions
       By: agate Date: July 13, 2024, 12:37 am
       ---------------------------------------------------------
       Looks as if the UK will be offering Ocrevus as 10-minute,
       hospital-administered injections.
       From The Guardian (July 12, 2024)--"MS patients in England
       offered 10-minute jab in place of infusions":
  HTML https://www.theguardian.com/society/article/2024/jul/12/multiple-sclerosis-england-10-minute-jab-ocrelizumab
       *****************************************************